Cambridge Investment Research Advisors
PJP icon

Cambridge Investment Research Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
10,109
+1,999
+25% +$211K ﹤0.01% 2135
2025
Q4 		$848K Sell
8,110
-722
-8% -$72.6K ﹤0.01% 2231
2025
Q3 		$817K Sell
8,832
-512
-5% -$44.8K ﹤0.01% 2214
2025
Q2 		$746K Sell
9,344
-344
-4% -$27.4K ﹤0.01% 2184
2025
Q1 		$839K Sell
9,688
-104
-1% -$8.86K ﹤0.01% 2005
2024
Q4 		$809K Sell
9,792
-28,053
-74% -$2.41M ﹤0.01% 2031
2024
Q3 		$3.29M Sell
37,845
-862
-2% -$73.8K 0.01% 1023
2024
Q2 		$3.18M Sell
38,707
-1,042
-3% -$82.8K 0.01% 999
2024
Q1 		$3.19M Sell
39,749
-912
-2% -$70.6K 0.01% 998
2023
Q4 		$3.09M Sell
40,661
-612
-1% -$43.8K 0.01% 956
2023
Q3 		$2.99M Buy
41,273
+27,786
+206% +$2.13M 0.01% 925
2023
Q2 		$1.02M Sell
13,487
-1,094
-8% -$83.5K ﹤0.01% 1600
2023
Q1 		$1.11M Sell
14,581
-864
-6% -$66.6K 0.01% 1509
2022
Q4 		$1.21M Buy
15,445
+2,555
+20% +$196K 0.01% 1382
2022
Q3 		$919K Sell
12,890
-2,116
-14% -$158K 0.01% 1536
2022
Q2 		$1.13M Buy
15,006
+1,825
+14% +$138K 0.01% 1399
2022
Q1 		$1.05M Sell
13,181
-1,573
-11% -$122K ﹤0.01% 1546
2021
Q4 		$1.2M Sell
14,754
-497
-3% -$39.3K 0.01% 1457
2021
Q3 		$1.18M Sell
15,251
-194
-1% -$15.6K 0.01% 1407
2021
Q2 		$1.24M Sell
15,445
-1,295
-8% -$103K 0.01% 1374
2021
Q1 		$1.32M Sell
16,740
-268
-2% -$20.9K 0.01% 1250
2020
Q4 		$1.21M Sell
17,008
-2,950
-15% -$197K 0.01% 1186
2020
Q3 		$1.27M Sell
19,958
-4,277
-18% -$280K 0.01% 1044
2020
Q2 		$1.57M Buy
24,235
+2,492
+11% +$155K 0.01% 884
2020
Q1 		$1.2M Buy
21,743
+2,359
+12% +$144K 0.01% 887
2019
Q4 		$1.25M Buy
19,384
+1,276
+7% +$77.6K 0.01% 1025
2019
Q3 		$1.03M Sell
18,108
-1,296
-7% -$74.6K 0.01% 1054
2019
Q2 		$1.17M Buy
19,404
+1,585
+9% +$97.2K 0.01% 951
2019
Q1 		$1.16M Sell
17,819
-2,589
-13% -$170K 0.01% 964
2018
Q4 		$1.27M Sell
20,408
-1,550
-7% -$105K 0.01% 817
2018
Q3 		$1.61M Buy
21,958
+920
+4% +$66K 0.02% 772
2018
Q2 		$1.41M Sell
21,038
-1,887
-8% -$121K 0.01% 796
2018
Q1 		$1.43M Sell
22,925
-1,429
-6% -$94.1K 0.02% 759
2017
Q4 		$1.56M Sell
24,354
-3,021
-11% -$194K 0.02% 682
2017
Q3 		$1.79M Sell
27,375
-379
-1% -$23.9K 0.02% 575
2017
Q2 		$1.74M Sell
27,754
-1,426
-5% -$85.6K 0.03% 573
2017
Q1 		$1.72M Sell
29,180
-685
-2% -$40.1K 0.03% 493
2016
Q4 		$1.67M Sell
29,865
-4,736
-14% -$273K 0.03% 488
2016
Q3 		$2.13M Buy
34,601
+2,991
+9% +$196K 0.04% 413
2016
Q2 		$2M Buy
31,610
+4,572
+17% +$288K 0.04% 382
2016
Q1 		$1.62M Sell
27,038
-14,966
-36% -$916K 0.04% 408
2015
Q4 		$2.94M Buy
42,004
+3,121
+8% +$221K 0.07% 264
2015
Q3 		$2.58M Sell
38,883
-37,013
-49% -$2.88M 0.07% 257
2015
Q2 		$5.95M Buy
75,896
+22,184
+41% +$1.73M 0.16% 132
2015
Q1 		$4.1M Buy
53,712
+3,735
+7% +$275K 0.12% 183
2014
Q4 		$3.33M Buy
49,977
+24,898
+99% +$1.66M 0.1% 187
2014
Q3 		$1.6M Sell
25,079
-131
-0.5% -$8.09K 0.05% 372
2014
Q2 		$1.54M Buy
25,210
+552
+2% +$32K 0.05% 335
2014
Q1 		$1.4M Buy
24,658
+5,117
+26% +$291K 0.05% 341
2013
Q4 		$1.04M Buy
19,541
+3,215
+20% +$161K 0.04% 382
2013
Q3 		$752K Buy
16,326
+4,758
+41% +$217K 0.03% 457
2013
Q2 		$489K Buy
+11,568
New +$481K 0.02% 558

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cambridge Investment Research Advisors's PJP Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Invesco Pharmaceuticals ETF (PJP) stake by 25% in Q1 2026, buying an estimated $211K and bringing the position to 10,109 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Cambridge Investment Research Advisors first reported a position in PJP in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.95M in Q2 2015. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Cambridge Investment Research Advisors held 10,109 shares of Invesco Pharmaceuticals ETF worth $1.05M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 1,999 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $211K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2135 holding.
  • Cambridge Investment Research Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
  • Cambridge Investment Research Advisors's Invesco Pharmaceuticals ETF position peaked at $5.95M in Q2 2015.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.